chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Slight aftertaste in my mouth 5 mins out., 20 minutes out i had a warm fuzzy feeling in my front stomach that stayed all afternoon. Around 10:17 I wasnt able to walk around for long periods of time bc I felt winded.  When I got home from the shot I slept for about 7 hrs
On the evening after receiving the IM injection in her L deltoid, this patient began experiencing some pain in her gums around one of her L lower molars. The following day the pain was more severe and had spread to the gums by her L lower incisor tooth. She also developed enlarged masses in the L submandibular and parotid areas (presumed lymphadenopathy). There was visible redness/injection on the gums around the L lower molar and incisor so on 11 Jan she went to the dentist, who consulted with a periodontist. The patient was determined to have otherwise healthy appearing teeth/gums and her X-rays were normal. They felt it must have been a reaction to the COVID vaccine and they referred her to me. I confirmed she has visible injection and tenderness on the gums around those two teeth, though the submandibular LAD seems to have resolved by then. We opted to monitor for the time being. I have since spoken with the patient and she reports the gingival pain improved a few days after I saw her, around 13 Jan. She has no residual symptoms as of 21 Jan.
Rash on left forearm; Chills; swollen lymph nodes; Sore right arm; This is a spontaneous report from a contactable other hcp (patient herself). A 55-year-old non-pregnant female patient (not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration, administered in Left arm on 29Jan2021 at 13:30 (at the age of 55-years-old) as a single dose for covid-19 immunisation. Medical history included first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: Unknown) administered in left arm on 08Jan2021 (at the age of 55-years-old) 13:30 for covid-19 immunisation, hypothyroidism, GERD, and unspecified allergies. Concomitant medication included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication received within 2 weeks of vaccination on an unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. On 30Jan2021 at 12: 00 AM, the patient experienced, Chills, swollen lymph nodes, Sore right arm, Rash on left forearm on day 4 and 5 post 2nd vaccine. No treatment was received for adverse event. The reporter assessed adverse events as non-serious with no seriousness criteria of resulting in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Per my aunt (uncle's wife), my uncle complained of severe headache especially on the right temple area, nausea, and dizziness at around 6am on 4/11/2021. Soon afterward, she noted my uncle has left side weakness and drooling when drinking.
Approximately 7 minutes after pt received her 2nd Covid Vaccine, pt reported that she felt dizzy. Also noted pt was red in the face.  Instructed pt to lay back and we put her legs up. Vital signs taken,  elevated (96 pulse and 156/90 bp). Her breathing was fine and she was alert. As we were speaking, her redness started to subside, but her dizziness persisted. I went to get her a bottle of water. RN then went to call Rapid Response who evaluated pt, administered Benadryl, and observed for extra time. Pt was then released and walked out on her own 2 feet.  Call to RRT at the vaccination clinic. Patient had sudden onset of dizziness/fogginess and left facial/neck rash a few minutes after taking the second Covid vaccine.  Patient stated she had similar rash a few hours later with her first Covid vaccine that self resolved.  She reported no chest pain, shortness of breath, throat/tongue swelling.  She reports no cardiac history/risk factors. Patient noted to be lying supine face/with a rash on her face and neck.  Vitals were noted to be stable(please see RN note).  Blood sugar 107. She was given 50 mg p.o. Benadryl and symptoms significantly improved as per RN.  Allergy to epinephrine.  She had a chaperone take her home.  Advised to continue benadryl Q6-8 hrs and  follow-up with PCP. ER precaution explained.
Itchy vesicular rash on lower right back 3 days after first vaccine dose. Redness and blistering. Itching resolved after treatment with topical steroid for ~7 days. Bumps have remained till now.
Starting the following morning, significant nerve pain on the left (other) side radiating from shoulder up the neck.
On-set of symptoms after 5 hours of injection. Severe allergic reaction, anaphylactic in nature, tiredness, full body pain, flu-like symptoms. Abated in 24 hours.
Feel like a zombie: can't stay awake, after booster; Feel like a zombie: can''t stay awake, after booster; feel tired; sleep more; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 70 year-old male patient received bnt162b2 (BNT162B2), administration date 30Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "severe diabetic" (unspecified if ongoing); "kidney transplant" (unspecified if ongoing); "Covid" (unspecified if ongoing), notes: had Covid around one year ago. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), administration date: Mar2021, for COVID-19 immunization; Bnt162b2 (Dose 2, single), administration date: Apr2021, for COVID-19 immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "Feel like a zombie: can't stay awake, after booster"; SOMNOLENCE (non-serious) with onset 2021, outcome "unknown", described as "Feel like a zombie: can''t stay awake, after booster"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "feel tired"; HYPERSOMNIA (non-serious) with onset 2021, outcome "unknown", described as "sleep more".  Additional information: Caller stated that, they both had the Booster dose and after that they feel tired all the time. It worn them all, it was hard to keep going feeling all tired all the time and they sleep more. Is report related to a study or programme: No  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Narrative:  First stroke on 5/22/2021, second stroke on 6/18/2021 and sent to hospital
p/vax pt started wheezing & diff swallowing;arrived @ hosp 12:30 p/calling around for appt, couldn't fine one;went to ER;recv solumedrol, DPH, epi, proventil/albuterol;stable by 250PM;
On 5/27/00, the pt received her 1st dose of Lymerix and within 1 1/2 hours, post vax, the pt experienced flu symptoms, headache, joint pain, and severe abdominal pain (in the ovary area). She also reported her menstrual period lasted 12 days. The most recent information received on 6/12/00 reports the outcome of the events as not yet recovered but resolving slowly.
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. No pertinent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored PEDVAXHIB (Lot# K025002, expiration date 20-JUL-2017, strength, route and dose not reported). No symptoms had been reported. This is one of two reports received from the same reporter. Additional information has been requested.
Developed welt (R) triceps 1 day after Varivax administered. Treated w/Benadryl, ice
Within 2 or 3 minutes my left arm was itching, within 10 minutes my head, chest and other arm were itching. I got lightheaded and for an instant felt like I was going to black out but didn't, in 15 mins my entire body was itching. I was given 1 Benedryl capsule orally and told to wait 15 more mins. The itching kept spreading, I started feeling like I was going into an asthma attack. They had me wait 15 more mins. It seemed to stop getting worse as quickly. They gave me another Benedryl and I left since I did have an Epi-pen with me. I got home and took another Benedryl about an hour later and about every 6 hours. I got up the next morning and felt horrible and was still itching so took more Benedryl. Tuesday night it felt like it was getting a little better but felt like I was having a slight asthma attack but my inhaler wasn't helping. On Friday I went to my family doctor and was put on a short dose of Prednisone, 20 mg twice a day for 5 days. It did help. Since I've gotten the shot, when I eat it's like my stomach bloats up and diarrhea and generally don't feel like myself. I was really tired until I got on the Prednisone. Each day I feel more like myself but not back to 100% yet. I started taking my Brio again to see if it would help.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021 at 10:56 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Apr-2021 at 10:56 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 27.30 for dose administered on 27-Apr-2021. No concomitant medications were reported.  Batch number 007C21A undergone temperature excursion on 27-Apr-2021 with temperature 35 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 19-Apr-2021 and beyond use date for the vial was reported as 19-May-2021. Product moved to clinic on 27-Apr-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.    This case was linked to MOD-2022-566976 (Patient Link).
Two inch diameter big, red area on arm appeared 2 days after shot, felt lethargic, headache, stomach ache. Saw doctor that day on 10/24/2001.
About one week after Covid booster and flu shot I started breaking out in hives, welts and, sandpaper like rashes. There have been no other changes to diet, atmosphere or medications. For two weeks the symptoms were very strong and very uncomfortable. I had multiple reactions everyday. At around two weeks it calmed down and I would go a day or two with nothing then would have breakouts, nothing seemed to trigger the reactions, but I could feel them come on. My hives would be considered dermatographia. I self treated with benedryl until I could get in for Doctor appointment at which point I was prescribed Zyrtec and have not had a reaction since being on it December 6, 2022.
The night of January 7, I began running a very high fever.  I went to the bathroom several times that night, getting weaker each time. Eventually, I fell and later passed out, waking up in the emergency room, and was admitted for several days.
Pt experenced a low grade fever roughly 24hrs after immunization which later progressed into a 103.5 degree fever and hospitalization.
pt had sz on 17MAY93 & was taken to ER; had sz again on 23MAY93 & is not being treated @ hosp as an in patient;
stoma broke out; sore arm; This spontaneous case was reported by a physician and describes the occurrence of STOMA SITE RASH (stoma broke out) and PAIN IN EXTREMITY (sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    The patient's past medical history included Depression, COVID-19 and Intestinal resection in 2018.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. On an unknown date, ADALIMUMAB (HUMIRA) (unknown route) dosage was changed to Citrate free. On an unknown date, the patient experienced STOMA SITE RASH (stoma broke out) and PAIN IN EXTREMITY (sore arm). At the time of the report, STOMA SITE RASH (stoma broke out) had resolved and PAIN IN EXTREMITY (sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2018, Intestinal resection: (Inconclusive) Intestinal resection Done in 2018..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not reported. Action taken with mRNA-1273 in response to the event was not applicable.   Reporter did not allow further contact
Shallow breathing, chest pains, intense headaches, similar to symptoms experienced when I had COVID a year ago. Occurred about 4 hours after receiving injection.. Comes in waves throughout the day.
patient received a 3rd dose moderna from pharmacy 8/18/21 . Patient received velcade 2.6mg on 8/25 and xpivio, kytril 1mg on 8/27, zometa 4mg on 8/18 . Was admitted on 8/27 to hospital with shortness of breath and nausea x 2 days. Igg on 89/27 was 0.02. ferritin was 165999.
Day following vaccination back erupted with moderately painful pustular rash across both sides.   Patient first came in after didn't resolve after 11 days as he assumed vaccine reaction.
shingle like rash on trunk and armpits; This case was reported by a pharmacist via call center representative and described the occurrence of vesicular rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2019, the patient received the 1st dose of Shingrix (intramuscular). In June 2019, less than a week after receiving Shingrix, the patient experienced vesicular rash. On an unknown date, the outcome of the vesicular rash was unknown.   It was unknown if the reporter considered the vesicular rash to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The reporter did not have patient demographics details. On 10th June 2019 or 11th June 2019, the patient received a dose of Shingrix at the pharmacy. On the day of reporting, the patient reported to the pharmacist a shingle like rash on his trunk and armpits. The reporter would call back to provide more details.
INTENSE headache (migraine) starting about 2 hours after injection and lasting 12+ hours.  Minor headache continues.  Muscle pain and swelling at site of injection about 2 hours after injection and continues
May 28 - Went to Bed and woke next morning and could not hear in Both ears - Still can't Hear Ear wax Remover
Rash all over my body and uncontrollable painful muscle spasms all over my body to the point that I could barely walk.
Stroke; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (Stroke) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CEREBROVASCULAR ACCIDENT (Stroke) (seriousness criterion medically significant). At the time of the report, CEREBROVASCULAR ACCIDENT (Stroke) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication use was reported.  Company comment: This case concerns a patient with of unknown age and gender with no relevant medical history reported, who experienced the unexpected event of cerebrovascular accident. The event occurred on an unknown number of days after an unknown number of doses of mRNA-1273. The rechallenge was unknown since no information regarding the number of the doses was disclosed. The benefit-risk relationship of mRNA-1273 in not affected by this report. There is no information indicating that the event is related to Moderna COVID-19 Vaccine. The case seems to be invalid.; Sender's Comments: This case concerns a patient with of unknown age and gender with no relevant medical history reported, who experienced the unexpected event of cerebrovascular accident. The event occurred on an unknown number of days after an unknown number of doses of mRNA-1273. The rechallenge was unknown since no information regarding the number of the doses was disclosed. The benefit-risk relationship of mRNA-1273 in not affected by this report. There is no information indicating that the event is related to Moderna COVID-19 Vaccine. The case seems to be invalid.
tenderness in calves;progressing to numbness in hands/feet;all over body aches;pain in all muscles; ER 9/5 observed;home & told to see MD 9/7-weak w/paralysis in hands & feet; hosp;home 9/15;in w/chair;very weak; paralysis fingers remain
Initially started with back, leg and foot pain.  Left arm and hand felt swollen and somewhat numb.  In about 12 hours it felt as if the other arm was numb as well.  Feet and legs were throbbing.  Face became "hard".  Went to the ED approximately 12 hours after administration of the vaccine.  Really weak and hard to walk.  Could not hold balance.  Did become hard to breathe while in the ED.  Gait then became very deliberate.  Had to "throw" legs to get them to move.
Two weeks after the 1st shot, I experienced a pain in my left hip. One month after the 2nd shot, I experience very significant additional discomfort in my left hip, knee, and shin, which became debilitating. I have been treated for arthritis, hip flexor damage, and other inflammation disorders. Seven months after 1st shot, I am experiencing some relief.
Information has been received from a health professional concerning a 15 year old female with a history of drug hypersensitivity to amoxicillin who on 27-AUG-2007 was vaccinated with her first dose of GARDASIL (lot 658222/0927U). Concomitant therapy included ORTHO TRI-CYCLEN, vitamins (unspecified) and RETIN-A. On 29-Oct-2007 the patient was vaccinated with her second dose of GARDASIL (lot 658558/1061U). On 27-AUG-2007 and 29-Oct-2007 the patient experienced pruritus at the injection site. The patient sought unspecified medical treatment. Subsequently, the patient recovered from pruritus at injection site after longer than a week. Additional information has been requested. No further information is expected.
Information has been received from a nurse practitioner and through a Merck Pregnancy Registry concerning a 20 year old female who on 20-FEB-2007 was vaccinated, intramuscularly with one dose of Gardasil. The patient discovered she was 9 weeks pregnant on 18-JUL-2007 with an estimated last menstrual period of approximately 16-MAY-2007. The pregnancy was terminated on 24-JUL-2007. It was reported that the termination was not due to Gardasil. No further information is available. Upon internal review termination of pregnancy was considered an other important medical event. Additional information has been requested.
On 8/31/05, grandmother states patient arms and legs got stiff and wouldn't respond to her for a few minutes. Parents took to ER and was admitted overnight.
Chills,  fever, muscle aches, severe headache starting 04/25/21 at 2am in the morning. Chills and fever subsided by 8 am but severe headache and aches sensitivity to light lasted till 9pm. Next morning  of 26th everything  subsided but cold sores started in left nasal cavity with pain and swelling. Got progressively worse.  04/29/22 started using saline nasal spray and anti bacterial ointment to treat. As of today is getting better 04/30/21 improving but not cleared up yet.
First dose of shringrix 4 months ago and now have shingles; Suffer from the PHN; So painful; Made me I'll for a day/ didn't work; This case was reported by a consumer via  source and described the occurrence of shingles in a 62-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   In January 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced shingles, post herpetic neuralgia, pain and unwell. On an unknown date, the outcome of the shingles was unknown and the outcome of the post herpetic neuralgia, pain and unwell were recovered/resolved.   It was unknown if the reporter considered the shingles, post herpetic neuralgia, pain and unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 61 or 62 years. After receiving 1st dose of Shingrix 4 months ago of the reporting date, the patient had experienced shingles and also suffered from PHN (Post Herpetic neuralgia). The patient reported that it was so painful. The patient experienced shingles for 2nd time and the patient was on no medication and exercises at least 5 days a week. The patient was not sure about receiving the 2nd dose because 1st dose made patient ill and did not work.